N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin

Human Pathology

Volumn 41, Issue 2, 2010, Pages 214-222

  Song, YooHyun ^a   Oda, Yoshinao ^a   Hori, Mikifumi ^a   Kuroiwa, Kentaro ^a   Ono, Mayumi ^b   Hosoi, Fumihito ^b   Basaki, Yuji ^b   Tokunaga, Shoji ^c   Kuwano, Michihiko ^b   Naito, Seiji ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Carcinogenesis; E cadherin; NDRG1 Cap43; Prognosis; Prostate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; DISEASE COURSE; DISEASE FREE SURVIVAL; DOWN REGULATION; GENE EXPRESSION; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE C MYB; PROSTATE CANCER; TUMOR GROWTH;

AGED; CADHERINS; CELL CYCLE PROTEINS; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIERS ESTIMATE; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS;

EID: 73749084834     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.07.011     Document Type: Article

References (30)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Han M., Partin A.W., Zahurak M., Piantadosi S., Epstein J.I., and Walsh P.C. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169 (2003) 517-523
3. Zhou D., Salnikow K., and Costa M. Cap43, a novel gene specifically induced by Ni2+ compounds. Cancer Res 58 (1998) 2182-2189
4. van Belzen N., Dinjens W.N., Diesveld M.P., et al. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 77 (1997) 85-92
5. Taketomi Y., Sugiki T., Saito T., et al. Identification of NDRG1 as an early inducible gene during in vitro maturation of cultured mast cells. Biochem Biophys Res Commun 306 (2003) 339-346
6. Piquemal D., Joulia D., Balaguer P., Basset A., Marti J., and Commes T. Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. Biochim Biophys Acta 1450 (1999) 364-373
7. Kurdistani S.K., Arizti P., Reimer C.L., Sugrue M.M., Aaronson S.A., and Lee S.W. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res 58 (1998) 4439-4444
8. Guan R.J., Ford H.L., Fu Y., Li Y., Shaw L.M., and Pardee A.B. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60 (2000) 749-755
9. Bandyopadhyay S., Pai S.K., Gross S.C., et al. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 63 (2003) 1731-1736
10. Bandyopadhyay S., Pai S.K., Hirota S., et al. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. Cancer Res 64 (2004) 7655-7660
11. Cangul H. Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet 5 (2004) 27
12. Cangul H., Salnikow K., Yee H., Zagzag D., Commes T., and Costa M. Enhanced expression of a novel protein in human cancer cells: a potential aid to cancer diagnosis. Cell Biol Toxicol 18 (2002) 87-96
13. Chen J., Li S., Yang Z., Lu G., and Hu H. Correlation between NDRG1 and PTEN expression in endometrial carcinoma. Cancer Sci 99 (2008) 706-710
14. Wang Z., Wang F., Wang W.Q., et al. Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm. World J Gastroenterol 10 (2004) 550-554
15. Chua M.S., Sun H., Cheung S.T., et al. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod Pathol 20 (2007) 76-83
16. Maruyama Y., Ono M., Kawahara A., et al. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res 66 (2006) 6233-6242
17. Angst E., Sibold S., Tiffon C., et al. Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer. Br J Cancer 95 (2006) 307-313
18. Fotovati A., Fujii T., Yamaguchi M., et al. 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells. Clin Cancer Res 12 (2006) 3010-3018
19. Koshiji M., Kumamoto K., Morimura K., et al. Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity. World J Gastroenterol 13 (2007) 2803-2810
20. Nishio S., Ushijima K., Tsuda N., et al. Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. Cancer Lett 264 (2008) 36-43
21. Umbas R., Isaacs W.B., Bringuier P.P., et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54 (1994) 3929-3933
22. Morton R.A., Ewing C.M., Nagafuchi A., Tsukita S., and Isaacs W.B. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Res 53 (1993) 3585-3590
23. De Marzo A.M., Knudsen B., Chan-Tack K., and Epstein J.I. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens. Urology 53 (1999) 707-713
24. Lachat P., Shaw P., Gebhard S., van Belzen N., Chaubert P., and Bosman F.T. Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol 118 (2002) 399-408
25. Stein S., Thomas E.K., Herzog B., et al. NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 279 (2004) 48930-48940
26. Kachhap S.K., Faith D., Qian D.Z., et al. The N-myc down regulated Gene1 (NDRG1) Is a Rab4a effector involved in vesicular recycling of E-cadherin. PLoS ONE 2 (2007) e844
27. Koksal I.T., Ozcan F., Kilicaslan I., and Tefekli A. Expression of E-cadherin in prostate cancer in formalin-fixed, paraffin-embedded tissues: correlation with pathological features. Pathology 34 (2002) 233-238
28. Rubin M.A., Mucci N.R., Figurski J., Fecko A., Pienta K.J., and Day M.L. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Hum Pathol 32 (2001) 690-697
29. Kuczyk M., Serth J., Machtens S., et al. Expression of E-cadherin in primary prostate cancer: correlation with clinical features. Br J Urol 81 (1998) 406-412
30. Caruso R.P., Levinson B., Melamed J., et al. Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with Caucasian prostate cancer patients. Clin Cancer Res 10 1 Pt 1 (2004) 222-227